Want to join the conversation?
$AKRX is maintaining its full-year 2016 financial guidance inclusive of net revenue of $1,060-1,080MM, GAAP diluted EPS of $1.56-1.66, and adjusted diluted EPS of $2.10-2.20. The guidance contemplates launches of products approved by the U.S. FDA as of May 10, 2016 along with the full year contribution of products launched in 2015.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.